Cder process documentation & development services
Ended Awarded Last action
- Contract number
- 75F40123F80116
- Awardee
-
Agisol LLC UEI G86VNCELJ5R3
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $231,769
Award facts
- Contract value 39% obligated
-
- $231,769.14 Current, with exercised options
- $597,096.99 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541519 Other Computer Related Services
- Set-aside
- 8(a) Sole Source
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Time and Materials
- Place of performance
- Silver Spring, MD 20993, USA
- Legislative mandates
-
- Clinger-Cohen Act FAR part 39
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Exercise an Option | $117,032 | |
| Other Administrative Action | $0 | |
| Original award | $114,737 |
About this award
This is a sole source 8(a) set-aside federal contract awarded by the Food and Drug Administration (FDA) to Agisol LLC, a small, minority-owned, woman-owned business. The contract is for $597,096.99 and provides process documentation and development services to the FDA's Center for Drug Evaluation and Research (CDER). The contract has a period of performance through August 21, 2028.
Agisol LLC, a certified 8(a) program participant, is the prime contractor for this contract. The company specializes in providing information technology services and solutions to federal agencies, with a focus on supporting the FDA's regulatory and administrative domains. Agisol has held multiple contracts with the FDA, including for document archiving, regulatory tracking system maintenance, process documentation, and workflow optimization.
This contract is part of Agisol's broader contract portfolio with the FDA, which includes work under the 8(a) STARS III Government-Wide Acquisition Contract (GWAC) and the GSA Multiple Award Schedule (MAS). These contract vehicles allow Agisol to provide specialized, mission-critical IT solutions to the FDA and other federal agencies.
Quick answers
Who was awarded contract 75F40123F80116?
75F40123F80116 was awarded to Agisol LLC by Food and Drug Administration (Department of Health and Human Services) on May 22, 2023.
How much is contract 75F40123F80116 worth?
The government has obligated $231,769 on 75F40123F80116. Its potential value, with all options, is $597,097.
Is contract 75F40123F80116 an order under another contract?
Yes. 75F40123F80116 is a delivery order under 47QTCA18D0071, a federal supply schedule, on Multiple Award Schedule (MAS).
Was contract 75F40123F80116 competed?
The extent of competition for 75F40123F80116 was full and open competition. The government received 1 offer. It was set aside: 8(a) Sole Source.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award